patanol
novartis israel ltd - olopatadine as hydrochloride - eye drops - olopatadine as hydrochloride 1 mg/ml - olopatadine - olopatadine - for the temporary prevention of itching of the eye due to allergic conjunctivitis.
dexamfetamine sulfate 1mg/ml oral solution
essential pharmaceuticals ltd - dexamfetamine sulfate - oral solution - 1mg/ml - psychoanaleptics; psychostimulants, agents used for adhd and nootropics; centrally acting sympathomimetics - it is indicated in the treatment of narcolepsy in adults
hypromellose 0.3% eye drops
a a h pharmaceuticals ltd - hypromellose - eye drops - 3mg/1ml
hypromellose 0.3% eye drops
almus pharmaceuticals ltd - hypromellose - eye drops - 3mg/1ml
aspirin 300mg tablets
almus pharmaceuticals ltd - aspirin - oral tablet - 300mg
cilostazol 100mg tablets
a a h pharmaceuticals ltd - cilostazol - oral tablet - 100mg
condyline
aft pharmaceuticals ltd - podophyllotoxin 5 mg/ml; podophyllotoxin 5 mg/ml - topical solution - 5 mg/ml - active: podophyllotoxin 5 mg/ml excipient: ethanol lactic acid purified water sodium lactate active: podophyllotoxin 5 mg/ml excipient: ethanol lactic acid purified water sodium lactate - condyline topical solution is indicated for external condylomata acuminata.
pdp-pyrazinamide
aft pharmaceuticals ltd - pyrazinamide 500mg; - tablet - 500 mg - active: pyrazinamide 500mg excipient: colloidal silicon dioxide microcrystalline cellulose pregelatinised maize starch starch stearic acid - pdp-pyrazinamide is indicated in patients with active tuberculosis caused by mycobacterium tuberculosis. pdp-pyrazinamide is not active against the atypical mycobacteria. pdp-pyrazinamide should be given only in combination with other effective anti-tuberculous agents.
tropisetron-aft
aft pharmaceuticals ltd - tropisetron hydrochloride 1.13 mg/ml equivalent to tropisetron 1 mg/ml - solution for injection - 1 mg/ml - active: tropisetron hydrochloride 1.13 mg/ml equivalent to tropisetron 1 mg/ml excipient: acetic acid sodium acetate trihydrate sodium chloride water for injection - prevention of nausea and vomiting induced by cytoxic therapy (5mg/5ml ampoule only).
vepesid
link pharmaceuticals ltd - etoposide 100mg - capsule - 100 mg - active: etoposide 100mg excipient: citric acid monohydrate gelatin glycerol iron oxide red macrogol 400 propyl hydroxybenzoate sodium ethyl hydroxybenzoate titanium dioxide water